Prevenar 13 0.5 ml (IM Injection)
0.5 ml pre-filled syringe: ৳ 7,400.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Polysaccharide pneumococcal vaccine |
| Company | Pfizer |
Indications
- Active immunization against pneumococcal disease
- Recommended for children aged 2 years and above
- Recommended for adolescents and adults
Pharmacology
- Prepared from purified pneumococcal capsular polysaccharide antigens
- Includes 23 serotypes accounting for 90% of invasive pneumococcal disease types
Dosage & Administration
- 0.5 mL dose for adults and children aged 2 years or older
- Administered by intramuscular or subcutaneous injection
- Special dosing considerations for elective splenectomy, chemotherapy, or immunosuppressive treatment
- Revaccination guidelines and intervals for adults and children
Interaction
- Can be administered simultaneously with influenza vaccine using separate needles and injection sites
Contraindications
- Allergic reactions to any vaccine component
- Fever, acute infection, or chronic diseases at acute stage
- Uncontrolled epilepsy or progressive nervous system diseases
Side Effects
- Common adverse reactions include injection-site pain, swelling, headache, erythema, asthenia, fatigue, and myalgia
Pregnancy & Lactation
- Use during pregnancy only if clearly necessary and justified by potential benefit
- Caution during nursing period
- Insufficient data on excretion in human milk and effects on reproductive toxicity
Precautions & Warnings
- Delay vaccine use in significant febrile illness or active infection
- Avoid intravascular or intradermal injection
- Considerations for immunosuppressed patients
- Availability of epinephrine for immediate use in case of acute anaphylactic reaction
- Prophylactic antibiotic therapy should not be stopped after vaccination
- Advice for patients at increased risk of serious pneumococcal infection
- Possible ineffectiveness in preventing infection resulting from basilar skull fracture or communication with cerebrospinal fluid
Therapeutic Class
- Vaccines, Anti-sera & Immunoglobulin
Storage Conditions
- Refrigerated storage at 2°C to 8°C
- Protection of vials from light